Physician profile
John K Waters
NPI 1710205208
$9,663.02
in general payments reported to CMS, 2019-2025
7 companies · $57.97 in 2025
The $57.97 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2021: $72.61 · 2022: $149 · 2023: $3,292 · 2024: $5,950 · 2025: $57.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,720 · Education: $3,000 · Travel and Lodging: $1,806 · Food and Beverage: $765 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,720.00 |
| Education | $3,000.00 |
| Travel and Lodging | $1,806.20 |
| Food and Beverage | $764.99 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,474.79 | 2019-2024 | Ion, Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $3,720.00 | 2024 | Tagrisso |
| W. L. Gore & Associates, INC. | $391.21 | 2021-2024 | Gore Tag Conformable Thoracic Stent Graft |
| Surmodics, INC. | $33.97 | 2025 | Pounce Thrombectomy System, Pounce Venous Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight |
| Depuy Synthes Sales INC. | $24.00 | 2025 | Matrixrib |
| Atricure, INC. | $19.05 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Waters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.